Aprea Therapeutics, Inc. (APRE) NASDAQ
0.72
+0.0116(+1.65%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.72
+0.0116(+1.65%)
Currency In USD
| Market Cap | 5.58M |
| Enterprise Value | -9.02M |
| P/E Ratio | -0.44 |
| PEG Ratio | -0.06 |
| Price/Sales Ratio | 16.26 |
| Price/Book Ratio | 0.42 |
| Enterprise/Revenue | -34.83 |
| Enterprise/EBITDA | 0.76 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -44.09 |
| Operating Margin | -46.31 |
| Return On Assets | -0.79 |
| Return On Equity | -0.94 |
| Revenue | 285,759 |
| Revenue/Share | 0.04 |
| Gross Profit | 264,044 |
| EBITDA | -13.23M |
| Net Income | -12.6M |
| Diluted EPS | -1.93 |
| Total Cash | 14.6M |
| Total Cash/Share | 1.9 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 5.63 |
| Book Value Per Share | 1.62 |
| 52-Week Change | -60.26 |
| 52-Week High | 2.22 |
| 52-Week Low | 0.55 |
| Moving Average 50 Days | 0.76 |
| Moving Average 200 Days | 1.25 |
| Average Volume | 2.32M |
| Shares Outstanding | 6.49M |
| % Held by Institutions | 26.6 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | February 13, 2023 |